Team

Leadership, Insight, Innovation.

Amy Abernethy, MD, PhD

Amy Abernethy, MD, PhD

Scientific Advisory Board

Amy is an internationally recognized expert in clinical trials, cancer outcomes research, health policy, health services research, patient reported outcomes, clinical informatics and patient-centered care.

Lee Babiss, PhD

Lee Babiss, PhD

Scientific Advisory Board

Lee has more than 21 years of experience in developing and leading research and development laboratories.

Matthew Boyer

Matthew Boyer

Director of Finance

Matt leverages his 15 years of experience to manage the daily financial operations and reporting for Pappas Ventures.

Kathrine Cays

Kathrine Cays

Senior Assistant | Deal Flow Coordinator

Kathrine's steady support helps our team get the details right.

Antonio Chow

Antonio Chow

Asia Regional Advisor

Antonio serves as the firm's Regional Advisor in Asia.

Glenda Crumpler

Glenda Crumpler

Executive Assistant

Glenda's broad strong organization skills help keep Pappas Capital running smoothly.

Lisa Dreyer

Lisa Dreyer

Senior Associate, Operations

Lisa brings a depth of experience in finance and operations from her years in the Alternative Investments industry.

Geoffrey Ginsburg, MD, PhD

Geoffrey Ginsburg, MD, PhD

Scientific Advisory Board

Geoff is an internationally recognized expert in genomics and personalized medicine.

Mike Grey

Mike Grey

Venture Partner

Mike’s extensive company management background enables him to bring an operational viewpoint to new deal opportunities and existing portfolio companies.

Franz Humer, PhD

Franz Humer, PhD

Venture Partner & Senior Advisor

Dr. Humer brings a wealth of leadership experience from the pharmaceutical and life science industries.

Russel Kaufman, MD

Russel Kaufman, MD

Executive-in-Residence & Scientific Advisory Board

With long-standing interests in both basic and applied cancer research, Russel has held leadership positions in national academic organizations in internal medicine.

Mankit Law, PhD

Mankit Law, PhD

Associate

Mankit has more than a decade of experience as a medical technologist and researcher, and is actively involved in identifying and evaluating new investment opportunities.

Ernie Mario, PhD

Ernie Mario, PhD

Venture Partner

Ernie has 45 years of experience in the research-based pharmaceutical industry.

Tom Mathers

Tom Mathers

Partner

Tom has more than 26 years of executive management experience in the life sciences and medical device industry.

James McNamara, MD

James McNamara, MD

Scientific Advisory Board

Jim has been a faculty member at Duke University for over 30 years, and is a highly regarded leader in the fields of neurology and neuroscience.

Barry Myers, MD, PhD

Barry Myers, MD, PhD

Executive-in-Residence

Barry has been a member of the Duke University faculty for 25 years. His broad base of expertise enables him to provide a distinctive view on portfolio companies.

Art Pappas

Art Pappas

Managing Partner

Art has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.

Kyle Rasbach, PhD, PharmD

Kyle Rasbach, PhD, PharmD

Partner

Kyle’s deep scientific experience and extensive background in equity research and public market investing bring an important skill set to Pappas Capital.

Martin Rosenberg, PhD

Martin Rosenberg, PhD

Scientific Advisory Board

Marty has published more than 210 papers and is the named inventor on more than 50 issued patents.

David Savello, PhD

David Savello, PhD

Venture Advisor & Scientific Advisory Board

Dave has an extensive career, holding senior level positions at companies such as Glaxo Inc., Glaxo Wellcome Inc., Warner Lambert Corporation and Boehringer Ingelheim Ltd.

Scott Weiner

Scott Weiner

Partner

Scott has an extensive background in healthcare investments, with a deep understanding of the life science market.

Bob White

Bob White

Senior Advisor

Bob has an extensive background in the medical device industry, including the successful sale of TYRX to Medtronic in 2013.

Ford Worthy

Ford Worthy

Partner

A lawyer by training, Ford oversees the firm’s financial and administrative activities.

Peter Young

Peter Young

Executive-in-Residence

Peter has more than thirty-five years of experience in the biotech and pharmaceutical industries, and leads the firm's efforts in translational medicine.